2025-04-01 16:15:00 ET
The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations and increased deals involving biotech stocks listed on the NASDAQ.
After dropping to a low of 3,637.05 in October 2023, the index climbed to a nearly three year peak of 4,954.813 on September 19, 2024. While the index had pulled back to 4,243.7 as of March 31, 2025, further growth could be in store in the future.
According to a Towards Healthcare analyst report , the global biotech market is expected to grow at a compound annual growth rate of 12.5 percent from now to 2034, reaching a valuation of US$5.036 trillion.
For further details see:
Top 5 Small-cap Biotech Stocks of 2025
